Researcher profile

Sam Beddar

Sam Beddar contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 19 - UnverifiedVerification L1Unclaimed author
5works
0followers
2topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

5 published item(s)

preprint2022arXiv

Automation of Radiation Treatment Planning for Rectal Cancer

To develop an automated workflow for rectal cancer three-dimensional conformal radiotherapy treatment planning that combines deep-learning(DL) aperture predictions and forward-planning algorithms. We designed an algorithm to automate the clinical workflow for planning with field-in-field. DL models were trained, validated, and tested on 555 patients to automatically generate aperture shapes for primary and boost fields. Network inputs were digitally reconstructed radiography, gross tumor volume(GTV), and nodal GTV. A physician scored each aperture for 20 patients on a 5-point scale(>3 acceptable). A planning algorithm was then developed to create a homogeneous dose using a combination of wedges and subfields. The algorithm iteratively identifies a hotspot volume, creates a subfield, and optimizes beam weight all without user intervention. The algorithm was tested on 20 patients using clinical apertures with different settings, and the resulting plans(4 plans/patient) were scored by a physician. The end-to-end workflow was tested and scored by a physician on 39 patients using DL-generated apertures and planning algorithms. The predicted apertures had Dice scores of 0.95, 0.94, and 0.90 for posterior-anterior, laterals, and boost fields, respectively. 100%, 95%, and 87.5% of the posterior-anterior, laterals, and boost apertures were scored as clinically acceptable, respectively. Wedged and non-wedged plans were clinically acceptable for 85% and 50% of patients, respectively. The final plans hotspot dose percentage was reduced from 121%($\pm$ 14%) to 109%($\pm$ 5%) of prescription dose. The integrated end-to-end workflow of automatically generated apertures and optimized field-in-field planning gave clinically acceptable plans for 38/39(97%) of patients. We have successfully automated the clinical workflow for generating radiotherapy plans for rectal cancer for our institution.

preprint2020arXiv

Evaluation of the Visibility and Artifacts of 11 Common Fiducial Markers for Image-Guided Stereotactic Body Radiation Therapy in the Abdomen

The purpose of this study was to quantitatively evaluate the visibility and artifacts of commercially available fiducial markers in order to optimize their selection for image-guided stereotactic body radiation therapy (SBRT). From six different vendors, we selected 11 fiducials commonly used in image-guided radiation therapy (IGRT); the fiducials varied in material composition (gold, platinum, carbon), shape (cylindrical, notched/linear, coiled, ball-like, step), and size measured in terms of diameter (0.28-1.0 mm) and length (3.0-20.0 mm). Each fiducial was centered in 4-mm bolus within a 13-cm-thick water-equivalent phantom. Fiducials were imaged with use of a simulation computed tomography (CT) scanner, a CT-on-rails system, and an onboard cone-beam CT system. Acquisition parameters were set according to clinical protocols. Visibility was assessed in terms of contrast and the Michelson visibility metric. Artifacts were quantified in terms of relative standard deviation and relative streak artifacts level (rSAL). Twelve radiation oncologists ranked each fiducial in terms of clinical usefulness. Contrast and artifacts increased with fiducial size. For CT imaging, maximum contrast (2722 HU) and artifacts (rSAL=2.69) occurred for the largest-diameter (0.75 mm) platinum fiducial. Minimum contrast (551 HU) and reduced artifacts (rSAL=0.65) were observed for the smallest-diameter (0.28 mm) gold fiducial. Carbon produced the least severe artifacts (rSAL = 0.29). The survey indicated that physicians preferred gold fiducials with a 0.35- to 0.43-mm diameter, 5- to 10-mm length, and a coiled or cylindrical shape that balanced contrast and artifacts. We evaluated 11 different fiducials in terms of visibility and artifacts. The results of this study may assist radiation oncologists who seek to maximize contrast, minimize artifacts, and/or balance contrast versus artifacts by fiducial selection.

preprint2020arXiv

From conception to clinical trial: IViST -- the first multi-sensor-based platform for real-time In Vivo dosimetry and Source Tracking in HDR brachytherapy

This study aims to introduce IViST (In Vivo Source Tracking), a novel multi-sensors dosimetry platform for real-time treatment monitoring in HDR brachytherapy. IViST is a platform that comprises 3 parts: 1) an optimized and characterized multi-point plastic scintillator dosimeter (3 points mPSD; using BCF-60, BCF-12, and BCF-10 scintillators), 2) a compact assembly of photomultiplier tubes (PMTs) coupled to dichroic mirrors and filters for high-sensitivity scintillation light collection, and 3) a Python-based graphical user interface used for system management and signal processing. IViST can simultaneously measure dose, triangulate source position, and measure dwell time. By making 100 000 measurements/s, IViST samples enough data to quickly perform key QA/QC tasks such as identifying wrong individual dwell time or interchanged transfer tubes. By using 3 co-linear sensors and planned information for an implant geometry (from DICOM RT), the platform can also triangulate source position in real-time. A clinical trial is presently on-going using the IViST system.

preprint2020arXiv

On the use of machine learning methods for mPSD calibration in HDR brachytherapy

Purpose: We sought to evaluate the feasibility of using machine learning algorithms for multipoint plastic scintillator detector calibration in high-dose-rate brachytherapy. Methods: The dosimetry system consisted of an optimized 1-mm-core mPSD and a compact assembly of photomultiplier tubes coupled with dichroic mirrors and filters. An $^{192}$Ir source was remotely controlled and sent to various positions in a homemade PMMA holder. Dose measurements covering a range of 0.5 to 12 cm of source displacement were carried out according to TG-43 recommendations. Individual scintillator doses were decoupled using a linear regression model, a random forest estimator, and artificial neural network algorithms. The performance of the different algorithms was evaluated using different sample sizes and distances to the source for the mPSD system calibration. Results: The decoupling methods' deviations from the expected TG-43 dose generally remained below 20%. However, the dose prediction with the three algorithms was accurate to within 7% relative to the dose predicted by the TG-43 formalism for measurements performed in the same range of distances used for calibration. The performance random forest was compromised when the predictions were done beyond the range of distances used for calibration. The dose prediction by the linear regression was less influenced by the calibration conditions than random forest, but with more significant deviations. The number of available measurements for training purposes influenced the random forest and neural network models the most. Their accuracy tended to converge toward deviation values close to 1% from a number of dwell positions greater than 100. Conclusions: In performing HDR brachytherapy dose measurements with an optimized mPSD system, ML algorithms are good alternatives for precise dose reporting and treatment assessment.

preprint2019arXiv

Dosimetric performance of a multi-point plastic scintillator dosimeter as a tool for real-time source tracking in high dose rate brachytherapy

Purpose: To present the performance of a multi-point plastic scintillation detector (mPSD) as a tool in vivo dosimetry in brachytherapy. Methods: A previously optimized three-point sensor system was used for in vivo HDR brachytherapy measurements (using the scintillators BCF-60, BCF-12, and BCF-10). The light detection system of the mPSD consisted of compactly assembled photomultiplier tubes (PMTs) and dichroic mirrors and filters to achieve a highly sensitive scintillation light collection. The PMT signals were recorded using a NI-DAQ board at a rate of 100 kHz. Dose measurements covering a range of 0.5 to 10 cm from the 192Ir source were carried out according to TG-43 U1 recommendations in order to: (1) characterize the system's response in terms of angular dependence; (2) obtain the relative contribution of positioning and measurement uncertainties to the total system uncertainty; (3) assess the system's temporal resolution; and (4) track the source position in real time. Results: The positioning uncertainty dominated close to the source, whereas the measurement uncertainty dominated at larger distances. A maximum measurement uncertainty of 17 % was observed for the BCF-60 scintillator at 10 cm from the source. The average best compromise between positioning and measurement uncertainties were reached at 17.4 mm. The detector further exhibited no angular dependence. The system provided an average location with a standard deviation under 1.7 mm. The maximum observed differences between measured and expected source location was 1.82 mm. Dose deviations remained below 5% in all the explored measurement conditions. With regard to dwell time measurement accuracy, the maximum deviation observed at all distances was 0.56 s. Conclusions: The performance of the system demonstrated that it could be used for real-time dose, position and dwell time measurements during HDR brachytherapy.